Proposed Data Collections Submitted for Public Comment and Recommendations, 76342-76343 [E6-21719]
Download as PDF
76342
Federal Register / Vol. 71, No. 244 / Wednesday, December 20, 2006 / Notices
Respondents & percent of form name use
ATSDR
ATSDR
ATSDR
ATSDR
ATSDR
ATSDR
Web
Web
Web
Web
Web
Web
site
site
site
site
site
site
Visitors
Visitors
Visitors
Visitors
Visitors
Visitors
Form name
Number of responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
(50%) ............................................
(15%) ............................................
(15%) ............................................
(5%) ..............................................
(8%) ..............................................
(7%) ..............................................
WSUS .........
TPUS ...........
TFUS ...........
PHSUS ........
TCCUS ........
TP–CDUS ...
1,000
300
300
100
160
140
1
1
1
1
1
1
5/60
5/60
5/60
5/60
5/60
5/60
83
25
25
8
13
12
Total ................................................................................
.....................
........................
........................
........................
166
Dated: December 14, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–21718 Filed 12–19–06; 8:45 am]
BILLING CODE 4163–18–P
Proposed Project
The Effectiveness of Teen Safe
Driving Messages and Creative Elements
on Parents and Teens—New—National
Center for Injury Prevention and Control
(NCIPC), Centers for Disease Control
and Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–06BU]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
sroberts on PROD1PC70 with NOTICES
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
VerDate Aug<31>2005
20:03 Dec 19, 2006
Jkt 211001
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Background and Brief Description
Car crashes are the number one killer
of teens, accounting for approximately
one-third of all deaths within this age
group. The National Center for Health
Statistics reports that in 2004, a total of
3,620 young drivers were killed and an
additional 303,000 were injured in
motor vehicle crashes.
In order to reduce these preventable
deaths and injuries, parental awareness
and education about Graduated Driver’s
Licensing (GDL) laws and the ways that
parents can influence their children’s
safe driving are necessary. In
preparation for a national campaign to
educate parents about their role in their
teens’ driver education, it is necessary
to determine the most effective
messages and channels through which
to communicate with parents.
Ogilvy Public Relations Worldwide,
on behalf of CDC, will conduct two
studies to assess the appropriateness
and impact of messages and creative
materials intended to (a) increase
parental involvement in their teen’s
driving education and experience, and
(b) encourage teens to adopt safer
driving practices.
The first information collection will
be accomplished through focus group
testing of campaign messages and
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
materials with representatives from our
target audiences, parents and teens, in
two cities in the U.S. The findings will
provide valuable information regarding
parents’ and teens’ levels of awareness
and concern about safe driving;
motivators for behavior change,
especially GDL compliance; and
message/channel preferences. The
information collected will be used to
develop final creative materials to
implement the teen safe driving
campaign in pilot cities.
The second information collection
will be accomplished through pilot city
testing, which will evaluate knowledge,
attitude and behaviors of intended
audiences both pre- and postcommunications campaign. The
campaign will target parents of newlylicensed drivers. It will encourage
parents to understand state regulations
regarding new drivers, talk with their
teens about safe driving practices, and
both manage and monitor their teens’
driving behavior. Testing will be
conducted through brief telephone
surveys intended to assess knowledge,
attitudes and behaviors of parents and
teens related to safe driving practices,
GDL laws, and parental management of
new drivers before and after the
campaign; with the goal of observing a
marked increase in parental
management at the time of the postcampaign survey. CDC anticipates
screening 1,777 individuals and that
45% of these will qualify for the survey
testing. Pending CDC’s decision whether
or not to include teens in survey testing,
the breakdown of the groups shown in
the tables below may change. However,
the total number of respondents and
screeners will remain the same.
There is no cost to the respondents
other than their time.
Estimated Annualized Burden Hours:
E:\FR\FM\20DEN1.SGM
20DEN1
76343
Federal Register / Vol. 71, No. 244 / Wednesday, December 20, 2006 / Notices
PHASE 1.—FOCUS GROUP TESTING
Estimated
number of responses per
respondent
Estimated
number of
respondents
Type of respondents
Average
burden per response
(in hours)
Annual total
burden
requested
(in hours)
Rejected Screeners .........................................................................................
Accepted Screeners ........................................................................................
Parents .............................................................................................................
Teens ...............................................................................................................
152
48
32
16
1.0
1.0
1.0
1.0
1/60
5/60
2.0
2.0
2
4
64
32
Total ..........................................................................................................
........................
........................
........................
102
PHASE 2.—PRE- AND POST-INTERVENTION PILOT CITY SURVEY TESTING
[based on two cities]
Estimated
number of responses per
respondent
Estimated
number of
respondents
Type of respondents
Average
burden per
response
(in hours)
Estimated annual total burden hours
requested
Screeners .........................................................................................................
Parents .............................................................................................................
Teens ...............................................................................................................
1,777
600
200
2.0
2.0
2.0
1/60
15/60
15/60
59
300
100
Total ..........................................................................................................
........................
........................
........................
459
Dated: December 13, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–21719 Filed 12–19–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857,301–827–
4659.
Food and Drug Administration
SUPPLEMENTARY INFORMATION:
BILLING CODE 4163–18–P
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
[Docket No. 2006N–0237]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Product
Jurisdiction: Assignment of Agency
Component for Review of Premarket
Applications
AGENCY:
Product Jurisdiction: Assignment of
Agency Component for Review of
Premarket Applications—(OMB Control
Number 0910–0523)—Extension
Food and Drug Administration,
HHS.
sroberts on PROD1PC70 with NOTICES
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by January 19,
2007.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
VerDate Aug<31>2005
20:03 Dec 19, 2006
Jkt 211001
This regulation relates to agency
management and organization and has
two purposes. The first is to implement
section 503(g) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 353(g)), as
added by the Safe Medical Devices Act
of 1990 (Public Law 101–629), and
amended by the Medical Device User
Fee and Modernization Act of 2002
(Public Law 107–250), by specifying
how FDA will determine the
organizational component within FDA
assigned to have primary jurisdiction for
the premarket review and regulation of
products that are comprised of any of
the following combinations: (1) A drug
and a device; (2) a device and a
biological; (3) a biological and a drug; or
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
(4) a drug, a device, and a biological.
The second purpose of this regulation is
to enhance the efficiency of agency
management and operations by
providing procedures for classifying and
determining which agency component
is designated to have primary
jurisdiction for any drug, device, or
biological product where such
jurisdiction is unclear or in dispute. The
regulation establishes a procedure by
which an applicant may obtain an
assignment or designation
determination. The regulation requires
that the request include the identity of
the applicant, a comprehensive
description of the product and its
proposed use, and the applicant’s
recommendation as to which agency
component should have primary
jurisdiction, with an accompanying
statement of reasons. The information
submitted would be used by FDA as the
basis for making the assignment or
designation decision. Most information
required by the regulation is already
required for premarket applications
affecting drugs, devices, biologicals, and
combination products. The respondents
will be businesses or other for-profit
organizations.
In the Federal Register of June 22,
2006 (71 FR 35916), FDA published a
60-day notice requesting public
comment on the information collection
provisions. No comments were received.
FDA estimates the burden of this
collection of information as follows:
E:\FR\FM\20DEN1.SGM
20DEN1
Agencies
[Federal Register Volume 71, Number 244 (Wednesday, December 20, 2006)]
[Notices]
[Pages 76342-76343]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-21719]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-07-06BU]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
The Effectiveness of Teen Safe Driving Messages and Creative
Elements on Parents and Teens--New--National Center for Injury
Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Car crashes are the number one killer of teens, accounting for
approximately one-third of all deaths within this age group. The
National Center for Health Statistics reports that in 2004, a total of
3,620 young drivers were killed and an additional 303,000 were injured
in motor vehicle crashes.
In order to reduce these preventable deaths and injuries, parental
awareness and education about Graduated Driver's Licensing (GDL) laws
and the ways that parents can influence their children's safe driving
are necessary. In preparation for a national campaign to educate
parents about their role in their teens' driver education, it is
necessary to determine the most effective messages and channels through
which to communicate with parents.
Ogilvy Public Relations Worldwide, on behalf of CDC, will conduct
two studies to assess the appropriateness and impact of messages and
creative materials intended to (a) increase parental involvement in
their teen's driving education and experience, and (b) encourage teens
to adopt safer driving practices.
The first information collection will be accomplished through focus
group testing of campaign messages and materials with representatives
from our target audiences, parents and teens, in two cities in the U.S.
The findings will provide valuable information regarding parents' and
teens' levels of awareness and concern about safe driving; motivators
for behavior change, especially GDL compliance; and message/channel
preferences. The information collected will be used to develop final
creative materials to implement the teen safe driving campaign in pilot
cities.
The second information collection will be accomplished through
pilot city testing, which will evaluate knowledge, attitude and
behaviors of intended audiences both pre- and post-communications
campaign. The campaign will target parents of newly-licensed drivers.
It will encourage parents to understand state regulations regarding new
drivers, talk with their teens about safe driving practices, and both
manage and monitor their teens' driving behavior. Testing will be
conducted through brief telephone surveys intended to assess knowledge,
attitudes and behaviors of parents and teens related to safe driving
practices, GDL laws, and parental management of new drivers before and
after the campaign; with the goal of observing a marked increase in
parental management at the time of the post-campaign survey. CDC
anticipates screening 1,777 individuals and that 45% of these will
qualify for the survey testing. Pending CDC's decision whether or not
to include teens in survey testing, the breakdown of the groups shown
in the tables below may change. However, the total number of
respondents and screeners will remain the same.
There is no cost to the respondents other than their time.
Estimated Annualized Burden Hours:
[[Page 76343]]
Phase 1.--Focus Group Testing
----------------------------------------------------------------------------------------------------------------
Estimated Average Annual total
Estimated number of burden per burden
Type of respondents number of responses per response (in requested (in
respondents respondent hours) hours)
----------------------------------------------------------------------------------------------------------------
Rejected Screeners.............................. 152 1.0 1/60 2
Accepted Screeners.............................. 48 1.0 5/60 4
Parents......................................... 32 1.0 2.0 64
Teens........................................... 16 1.0 2.0 32
---------------------------------------------------------------
Total....................................... .............. .............. .............. 102
----------------------------------------------------------------------------------------------------------------
Phase 2.--Pre- and Post-Intervention Pilot City Survey Testing
[based on two cities]
----------------------------------------------------------------------------------------------------------------
Estimated Average Estimated
Estimated number of burden per annual total
Type of respondents number of responses per response (in burden hours
respondents respondent hours) requested
----------------------------------------------------------------------------------------------------------------
Screeners....................................... 1,777 2.0 1/60 59
Parents......................................... 600 2.0 15/60 300
Teens........................................... 200 2.0 15/60 100
---------------------------------------------------------------
Total....................................... .............. .............. .............. 459
----------------------------------------------------------------------------------------------------------------
Dated: December 13, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-21719 Filed 12-19-06; 8:45 am]
BILLING CODE 4163-18-P